Capricor Therapeutics (CAPR) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to 0.22.
- Capricor Therapeutics' Asset Utilization Ratio fell 4856.84% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year decrease of 4856.84%. This contributed to the annual value of 0.35 for FY2024, which is 2457.08% down from last year.
- Per Capricor Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.22 for Q3 2025, which was down 4856.84% from 0.22 recorded in Q2 2025.
- Capricor Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.74 during Q2 2024, with a 5-year trough of 0.0 in Q1 2022.
- In the last 5 years, Capricor Therapeutics' Asset Utilization Ratio had a median value of 0.2 in 2023 and averaged 0.22.
- Per our database at Business Quant, Capricor Therapeutics' Asset Utilization Ratio tumbled by 9440.17% in 2021 and then skyrocketed by 267357.58% in 2023.
- Over the past 5 years, Capricor Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.01 in 2021, then soared by 745.62% to 0.05 in 2022, then surged by 970.54% to 0.53 in 2023, then tumbled by 34.81% to 0.34 in 2024, then plummeted by 35.16% to 0.22 in 2025.
- Its last three reported values are 0.22 in Q3 2025, 0.22 for Q2 2025, and 0.22 during Q1 2025.